424 related articles for article (PubMed ID: 37093521)
1. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery.
Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K
BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521
[TBL] [Abstract][Full Text] [Related]
2. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
3. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
[TBL] [Abstract][Full Text] [Related]
4. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
6. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
[TBL] [Abstract][Full Text] [Related]
7. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
Liu Q; Li D; Pan X; Liang Y
J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
[TBL] [Abstract][Full Text] [Related]
9. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
10. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display.
Antes TJ; Middleton RC; Luther KM; Ijichi T; Peck KA; Liu WJ; Valle J; Echavez AK; Marbán E
J Nanobiotechnology; 2018 Aug; 16(1):61. PubMed ID: 30165851
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle-based drug delivery systems for cancer treatment.
Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
[TBL] [Abstract][Full Text] [Related]
12. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
[TBL] [Abstract][Full Text] [Related]
13. Cancer Therapy Empowered by Extracellular Vesicle-Mediated Targeted Delivery.
Chen Y; Huang Y; Deng Y; Liu X; Ye J; Li Q; Luo Y; Lin Y; Liang R; Wei J; Zhang J; Li Y
Biol Pharm Bull; 2023; 46(10):1353-1364. PubMed ID: 37779037
[TBL] [Abstract][Full Text] [Related]
14. Targeting Inflammatory Vasculature by Extracellular Vesicles.
Wang S; Dong X; Gao J; Wang Z
AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
[TBL] [Abstract][Full Text] [Related]
15. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
16. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
[TBL] [Abstract][Full Text] [Related]
17. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles: a rising star for therapeutics and drug delivery.
Du S; Guan Y; Xie A; Yan Z; Gao S; Li W; Rao L; Chen X; Chen T
J Nanobiotechnology; 2023 Jul; 21(1):231. PubMed ID: 37475025
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid delivery with extracellular vesicles.
Schulz-Siegmund M; Aigner A
Adv Drug Deliv Rev; 2021 Jun; 173():89-111. PubMed ID: 33746014
[TBL] [Abstract][Full Text] [Related]
20. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
Nasiri Kenari A; Cheng L; Hill AF
Methods; 2020 May; 177():103-113. PubMed ID: 31917274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]